Ciliary sulcus-to-sulcus (STS) diameter is most accurately measured using ultrasound biomicroscopy (UBM).
Ciliary sulcus-to-sulcus (STS) diameter is most accurately measured using ultrasound biomicroscopy (UBM), according to a paper published in the Journal of Cataract and Refractive Surgery.
The study, led by Dr Julia Biermann, University Eye Hospital Freiberg im Breisgau, Germany, measured the STS diameter at 0, 45, 90 and 135 degrees using 35 MHz UBM. The Orbscan scanning-slit topography and the partial coherence interferometry (PCI) biometry (IOLMaster) were used to obtain the 0-degree automated horizontal white-to-white (WTW) diameter.
The 90˚ STS and the 0˚ STS were compared using the paired t test and the Pearson correlation was used to determine whether the 0˚ STS diameter could be predicted from the 0˚ WTW diameter.
In emmetropic and myopic eyes the mean SE refraction was −0.48 D ± 0.35 SD and −9.55 ± 3.70 D, respectively.
The 90˚ STS was greater than 0˚ STS in 35 of the 37 eyes studied. The mean 90˚ STS and 0˚ STS were 12.51 ± 0.43 mm and 12.19 ± 0.47 mm, respectively. The mean scanning-slit topography of 0˚ WTW diameters were 11.73 ± 0.37 mm and for the PCI biometry they were 12.20 ± 0.42 mm.
A strong correlation was found between 0˚ STS and 0˚ WTW with PCI biometry and scanning-slit topography in emmetropic eyes. However, the correlation was weaker in myopic eyes.
Overall, UBM is the most accurate way to measure sulcus diameter measurements. The study also suggests that WTW diameter is not suitable for determining a posterior chamber phakic intraocular lens (PC pIOL) diameter- especially in myopic eyes.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.
AAO 2024: Optimal pupil size reduction percentage for near vision improvement in presbyopia
October 21st 2024Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.